Hughes M Courtney, Vernon Erin, Egwuonwu Chinenye, Afolabi Oluwatoyosi
School of Health Studies, Northern Illinois University, Wirtz Hall 209, DeKalb, IL 60115, USA.
Department of Economics, Seattle University, Pigott 522, Seattle, WA 98122, USA.
PEC Innov. 2024 Mar 13;4:100273. doi: 10.1016/j.pecinn.2024.100273. eCollection 2024 Dec.
To systematically review research analyzing the effectiveness of decision aids for end-of-life care, including how researchers specifically measure decision aid success.
We conducted a systematic review synthesizing quantitative, qualitative, and mixed-methods study results using Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines. Four databases were searched through February 18, 2023. Inclusion criteria required articles to evaluate end-of-life care decision aids. The review is registered under PROSPERO (#CRD42023408449).
A total of 715 articles were initially identified, with 43 meeting the inclusion criteria. Outcome measures identified included decisional conflict, less aggressive care desired, knowledge improvements, communication improvements, tool satisfaction, patient anxiety and well-being, and less aggressive care action completed. The majority of studies reported positive outcomes especially when the decision aid development included International Patient Decision Aid Standards.
Research examining end of life care decision aid use consistently reports positive outcomes.
This review presents data that can guide the next generation of decision aids for end-of-life care, namely using the International Patient Decision Aid Standards in developing tools and showing which tools are effective for helping to prevent the unnecessary suffering that can result when patients' dying preferences are unknown.
系统回顾分析临终关怀决策辅助工具有效性的研究,包括研究人员具体如何衡量决策辅助工具的成功。
我们按照系统评价与Meta分析的首选报告项目指南,对定量、定性和混合方法的研究结果进行了系统回顾。检索了四个数据库,截至2023年2月18日。纳入标准要求文章评估临终关怀决策辅助工具。该综述已在国际系统评价注册库(PROSPERO)注册(#CRD42023408449)。
初步共识别出715篇文章,其中43篇符合纳入标准。确定的结局指标包括决策冲突、期望的积极治疗减少、知识改善、沟通改善、工具满意度、患者焦虑和幸福感,以及完成的积极治疗行动减少。大多数研究报告了积极的结果,特别是当决策辅助工具的开发符合国际患者决策辅助工具标准时。
关于临终关怀决策辅助工具使用的研究一致报告了积极的结果。
本综述提供的数据可指导下一代临终关怀决策辅助工具,即在开发工具时使用国际患者决策辅助工具标准,并展示哪些工具对于帮助预防因患者临终偏好不明而可能导致的不必要痛苦有效。